If you’re an innovator or inventor of small molecule and biologic therapeutics, you’ll need to protect your substantial investment in bringing a new product to market while making sure you are complying with all regulations.
Our lawyers have been integrating legal strategy with the commercial interests of our pharmaceutical clients for decades. We can help from start to finish of your invention, from product pipeline IP freedom to operate strategies, IP protection and litigation, clinical trials, licensing, marketing and advertising, and product development and supply agreements.
Pharma and biotech is second nature to us. Many of our people have technical degrees and backgrounds in chemistry and life sciences, as well as law degrees, meaning we understand both the science and the law surrounding your innovations.
Drawing on this experience, we will work closely with you to help achieve your business and financial goals through licensing and other monetization. We can also help you develop offensive and defensive Hatch-Waxman and Biosimilars strategies and facilitate cooperation, as we recently did between some major pharma clients and a large non-profit organization seeking to battle tuberculosis.
Ultimately, we know how to protect your IP and what regulators are looking for in every jurisdiction across the globe. Our aim is to get your drugs and biotech out into the world, working and healing.
- advising a Hong Kong biotech company, which specialises in developing diagnostic solutions, on its pre-IPO investment activities and corporate governance arrangements
Uusimmat Artikkelit
- legal updatesGlobal Health & Life Sciences Bulletin
- legal updatesGlobal Life Sciences & Healthcare Bulletin
- legal updatesGlobal Supply Chain Horizons - July 2025
- legal updatesGlobal Health and Life Sciences Newsletter Edition 12
Uusimmat Uutiset
legal updates
04. maaliskuuta 2026
Global Health & Life Sciences Bulletin
legal updates
03. joulukuuta 2025
Global Life Sciences & Healthcare Bulletin
legal updates
22. heinäkuuta 2025
Global Supply Chain Horizons - July 2025
legal updates
17. heinäkuuta 2025
Global Health and Life Sciences Newsletter Edition 12